Search results
Sofia the First Season 4 Streaming: Watch & Stream Online via Disney Plus
COMINGSOON.net via Yahoo News· 1 hour agoSofia the First Season 4 is all about Princess Sofia facing a new challenge: a powerful, villainous...
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
Zacks via Yahoo Finance· 3 months agoVor Bio (VOR) stock gains after dosing the first patient in its phase I/II study of novel cell...
Vor Biopharma Inc. (NASDAQ:VOR) Shares Could Be 43% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for Vor Biopharma is US$9.25 based on 2 Stage Free Cash Flow...
Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private equity firms control 43%...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Vor Biopharma's significant private equity firms ownership suggests that the key...
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 7 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 1 year agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 1 month agoJust because a business does not make any money, does not mean that the stock will go down. For...
Can Vor Biopharma Inc. (VOR) Climb 298% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe consensus price target hints at a 298.3% upside potential for Vor Biopharma Inc. (VOR). While...
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
Benzinga via Yahoo Finance· 11 months agoVor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase...
Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant
Benzinga via Yahoo Finance· 1 year agoVor Biopharma Inc (NASDAQ: VOR) presented clinical data from VBP101, its Phase 1/2a study of...